Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02308436
Other study ID # P11-4-MW15.042
Secondary ID
Status Withdrawn
Phase N/A
First received November 27, 2014
Last updated August 27, 2015
Start date February 2015
Est. completion date March 2015

Study information

Verified date August 2015
Source Mibelle AG
Contact n/a
Is FDA regulated No
Health authority Switzerland: Ethikkommission
Study type Interventional

Clinical Trial Summary

In vitro results showed a protective effect against acids for the mouthwash containing Curolox™ peptide. The goal of this in situ study is to detect the Curolox™ peptide under natural oral conditions on the tooth surface and to proof the in vitro results obtained. So far there are no effect and safety data of the Curolox™ mouthwash under natural oral conditions available.


Description:

The primary objective of the study is the detection of the Curolox™ peptide on the bovine enamel sample (proof-of-concept) under in vivo conditions after rinsing with the peptide-containing mouth wash.

Secondary Objectives

The secondary objectives of the study are:

1. safety and tolerance of the mouthwash in participants

2. identification of the duration the Curolox™ peptide is present on the bovine tooth surface under in vivo conditions

3. identification of the most effective mouthwash rinsing volume (2.5 mL or 5 mL)

4. prophylactic effect of multiple applications of the mouthwash confirmation of the prophylactic effect of the Curolox™ peptide obtained in in vitro study


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date March 2015
Est. primary completion date March 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Willing and able to understand and to follow the study procedures and instructions

- Willing to wear a dental appliance for 7 days

- Willing and able to attend the on-study visits

- Good oral hygiene throughout the study

- Written informed consent before participation in the study

Exclusion Criteria:

- Volunteer with an active periodontal disease or periodontal surgery < 1 year prior to study participation

- Volunteer with hypersensitive teeth or with any other (painful) oral pathology or defect

- Volunteer with an orthodontic appliance

- Volunteer undergoing a medical treatment

- Volunteer who is allergic to dental products

- Pregnant and lactating woman

- Concurrent participation in another clinical trial

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Device:
Candida Mouthwash with Curolox™ Peptide
Prophylaxis - protection and care of teeth against caries & acidic challenges

Locations

Country Name City State
Switzerland Aeskulap Klinik Brunnen

Sponsors (1)

Lead Sponsor Collaborator
Mibelle AG

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Detection of Curolox peptide by mass spectroscopy The primary outcome is the detection of the Curolox™ peptide on the bovine enamel sample immediately after rinsing with the peptide-containing mouth wash by mass spectroscopy Immediately after rinsing with the mouthwash No
Secondary Detection of Curolox peptide by mass spectroscopy The secondary outcome is the detection of the Curolox™ peptide on the bovine enamel sample 12 hours, 24 hours, 48 hours and 96 hours after rinsing with the peptide-containing mouth wash by mass spectroscopy 12 hours, 24 hours, 48 hours, 96 hours No